ADV - OCGN DNMR and DERM are among pre market gainers
2024-03-26 08:33:50 ET
More on premarket gainers & stock
- Journey Medical Corporation (DERM) Q4 2023 Earning Call Transcript
- Ocugen: A Speculative Buy In Biotech Growing Clinical Trials To Billion-Dollar Revenues
- Ocugen shares make gains after US court dismisses class action lawsuits
- Ocugen hits a 52-week high after decision to lower quorum requirement
- Seeking Alpha’s Quant Rating on Journey Medical